Gang Weijuan, Jing Xianghong
Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Zhongguo Zhen Jiu. 2017 Nov 12;37(11):1238-42. doi: 10.13703/j.0255-2930.2017.11.027.
In recent years, more and more patients of polycystic ovary syndrome (PCOS) have strong desire to be treated with acupuncture. In "Effect of acupuncture and clomiphene in Chinese women with polycystic ovary syndrome: a randomized clinical trial" published in () on June 27, 2017, the finding of this research does not support acupuncture for such infertility women. The questions and doubts are proposed in the paper from the regimen of acupuncture treatment, the determination of primary outcome and the explanation of the results. It is found by comparison that the trigger point treatment in the article is different from traditional acupuncture, there is doubt in live birth rate as the primary outcome, 4-month treatment is not enough for the change of live birth rate, difference without statistic significance between acupuncture and control acupuncture does not mean invalid acupuncture because the control acupuncture is not invalid, the research and statistic method are not those planned. As a result, we consider that the conclusion is unreasonable.
近年来，越来越多的多囊卵巢综合征（PCOS）患者强烈希望接受针灸治疗。在2017年6月27日发表于（）的《针刺与克罗米芬治疗中国多囊卵巢综合征女性的疗效：一项随机临床试验》中，该研究结果不支持对这类不孕女性采用针灸治疗。论文从针灸治疗方案、主要结局的判定以及结果的解释等方面提出了疑问。经比较发现，文中的触发点治疗与传统针灸不同，将活产率作为主要结局存在疑问，4个月的治疗时间对于活产率的改变而言不足够，针刺组与对照针刺组之间无统计学意义的差异并不意味着针刺无效，因为对照针刺并非无效，且研究及统计方法并非预先计划的那些。因此，我们认为该结论不合理。
